Case Report| Volume 19, ISSUE 3, PB3, March 2018

A Case of Flecainide Induced Cardiac Arrythmia Due to Polypharmacy

      Flecainide is a class IC anti-arrhythmic agent recommended for maintenance of sinus rhythm in patients with atrial fibrillation and/or supraventricular tachycardia who don't have structural heart disease. Flecainide is well known to be pro-arrhythmic as well. Polypharmacy is defined as taking four or more drugs by a patient. Polypharmacy is common in eledryl population with an estimated prevalence of 40%. Polypharmacy poses a significant hazard due to significant durg-drug interactions.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the American Medical Directors Association
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect